Deedra Nicolet

5.0k total citations
44 papers, 1.0k citations indexed

About

Deedra Nicolet is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Deedra Nicolet has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 26 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Deedra Nicolet's work include Acute Myeloid Leukemia Research (35 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Deedra Nicolet is often cited by papers focused on Acute Myeloid Leukemia Research (35 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Deedra Nicolet collaborates with scholars based in United States, Belgium and Germany. Deedra Nicolet's co-authors include Clara D. Bloomfield, Krzysztof Mrózek, Jonathan E. Kolitz, Jessica Kohlschmidt, Richard M. Stone, John C. Byrd, Andrew J. Carroll, Ann‐Kathrin Eisfeld, Bayard L. Powell and James S. Blachly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Deedra Nicolet

40 papers receiving 1.0k citations

Peers

Deedra Nicolet
Comparison fields: 5 of 74
  • Hematology 604
  • Molecular Biology 548
  • Cancer Research 341
  • Genetics 192
  • Public Health, Environmental and Occupational Health 144
Replace Juan Guo with:
Juan Guo China
Judith Neukirchen Germany
Varsha Muralidhar United States
H.C. Kwaan United States
Chengming Fei China
Alan Hair United Kingdom
Marianne Bach Treppendahl Denmark
Kosei Oshima United States
C.C So China
Toshio Shigekiyo Japan
Juan Guo China View profile →
Citations per field, relative to Deedra Nicolet
Deedra Nicolet · 1×
Citations per year, relative to Deedra Nicolet
Deedra Nicolet · 1×

Countries citing papers authored by Deedra Nicolet

Since Specialization
Citations

This map shows the geographic impact of Deedra Nicolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deedra Nicolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deedra Nicolet more than expected).

Fields of papers citing papers by Deedra Nicolet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deedra Nicolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deedra Nicolet. The network helps show where Deedra Nicolet may publish in the future.

Co-authorship network of co-authors of Deedra Nicolet

This figure shows the co-authorship network connecting the top 25 collaborators of Deedra Nicolet. A scholar is included among the top collaborators of Deedra Nicolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deedra Nicolet. Deedra Nicolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies
2025 ·Leukemia ·(unknown), Deedra Nicolet, (unknown), Daelynn R. Buelow, Shelley Orwick, Charles T. Gregory, (unknown), (unknown), Jonathan E. Kolitz, Bayard L. Powell, William Blum, Maria R. Baer, John C. Byrd, Wendy Stock, Geoffrey L. Uy, Krzysztof Mrózek, Ann‐Kathrin Eisfeld, Xiaolin Cheng, Sharyn D. Baker, James S. Blachly
1
2
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia
2024 ·The Innovation ·Kellie J. Archer, (unknown), Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Wolfgang Hiddemann, Klaus H. Metzeler, Christian Rausch, Utz Krug, Cristina Sauerland, Dennis Görlich, Wolfgang E. Berdel, Bernhard J. Woermann, Jan Braess, Karsten Spiekermann, Tobias Herold, Ann‐Kathrin Eisfeld
1
3
Association of social deprivation with survival in younger adult patients with AML: an Alliance study
2023 ·Blood Advances ·(unknown), Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly, Shelley Orwick, Karilyn Larkin, Christopher C. Oakes, Andrew Hantel, Andrew J. Carroll, William Blum, Bayard L. Powell, Geoffrey L. Uy, Richard M. Stone, Richard A. Larson, John C. Byrd, Electra D. Paskett, Jesse J. Plascak, Ann‐Kathrin Eisfeld
5
4
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
2023 ·Leukemia ·Krzysztof Mrózek, Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer, Alice S. Mims, Karilyn Larkin, Shelley Orwick, Christopher C. Oakes, Jonathan E. Kolitz, Bayard L. Powell, William Blum, Guido Marcucci, Maria R. Baer, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Ann‐Kathrin Eisfeld
31
5
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
2023 ·Blood Advances ·Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley Orwick, Daelynn R. Buelow, (unknown), Christopher C. Oakes, Jonathan E. Kolitz, Geoffrey L. Uy, Wendy Stock, Bayard L. Powell, Deedra Nicolet, Erin Hertlein, Krzysztof Mrózek, James S. Blachly, Ann‐Kathrin Eisfeld, Sharyn D. Baker, John C. Byrd
1
6
Impact of Cytarabine Pharmacogenomics on Survival of Adolescent and Young Adults with AML and Its Clinical Relevance in Black Patients
2023 ·Blood ·(unknown), Deedra Nicolet, (unknown), Krzysztof Mrózek, Christopher J. Walker, William Blum, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Geoffrey L. Uy, Wendy Stock, Andrew J. Carroll, John C. Byrd, Ann‐Kathrin Eisfeld, Jatinder K. Lamba
0
7
A precision medicine classification for treatment of acute myeloid leukemia in older patients
2021 ·Journal of Hematology & Oncology ·Alice S. Mims, Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld, Dimitrios Papaioannou, Deedra Nicolet, Krzysztof Mrózek, Eytan M. Stein, Bhavana Bhatnagar, Richard M. Stone, Jonathan E. Kolitz, Eunice S. Wang, Bayard L. Powell, Amy Burd, Ross L. Levine, Brian Druker, Clara D. Bloomfield, John C. Byrd
10
8
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years
2020 ·Leukemia ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Alice S. Mims, Deedra Nicolet, Christopher J. Walker, James S. Blachly, Andrew J. Carroll, Dimitrios Papaioannou, Jonathan E. Kolitz, (unknown), Richard M. Stone, Albert de la Chapelle, John C. Byrd, Krzysztof Mrózek, Clara D. Bloomfield
56
9
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
2019 ·Molecular Cancer Therapeutics ·Dimitrios Papaioannou, Deedra Nicolet, Hatice Gülçin Özer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield
12
10
Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
2019 ·Haematologica ·Marius Bill, Deedra Nicolet, Jessica Kohlschmidt, Christopher J. Walker, Krzysztof Mrózek, Ann‐Kathrin Eisfeld, Dimitrios Papaioannou, Xiaoqing Rong, (unknown), Jonathan E. Kolitz, Bayard L. Powell, Kellie J. Archer, Adrienne M. Dorrance, Andrew J. Carroll, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield
13
11
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21
2019 ·Leukemia ·Bhavana Bhatnagar, Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Dimitrios Papaioannou, Christopher J. Walker, Shelley Orwick, James S. Blachly, Jonathan E. Kolitz, Bayard L. Powell, Andrew J. Carroll, Richard M. Stone, John C. Byrd, Clara D. Bloomfield
5
12
Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
2018 ·Blood ·Marius Bill, Dario Veneziano, Jessica Kohlschmidt, Krzysztof Mrózek, Giovanni Nigita, (unknown), Deedra Nicolet, Dimitrios Papaioannou, Allison R. Walker, (unknown), Bayard L. Powell, Richard M. Stone, Geoffrey L. Uy, Jonathan E. Kolitz, Eunice S. Wang, Adrienne M. Dorrance, Carlo M. Croce, Ramiro Garzon, Clara D. Bloomfield
2
13
Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category
2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Alice S. Mims, Christopher J. Walker, James S. Blachly, Deedra Nicolet, Shelley Orwick, (unknown), Andrew J. Carroll, Bayard L. Powell, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield
0
14
Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies
2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, James S. Blachly, Christopher J. Walker, Deedra Nicolet, Shelley Orwick, Andrew J. Carroll, Richard M. Stone, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield
0
15
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
2017 ·Leukemia ·(unknown), Krzysztof Mrózek, Jessica Kohlschmidt, Deedra Nicolet, Shelley Orwick, Christopher J. Walker, (unknown), James S. Blachly, A J Carroll, Jonathan E. Kolitz, Bayard L. Powell, Eunice S. Wang, Richard M. Stone, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield
48
16
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
2016 ·Cancer Research ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Stefano Volinia, James S. Blachly, Deedra Nicolet, Christopher C. Oakes, (unknown), Shelley Orwick, Andrew J. Carroll, Richard M. Stone, John C. Byrd, Albert de la Chapelle, Clara D. Bloomfield
16
17
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)
2016 ·Haematologica ·Christian Niederwieser, Deedra Nicolet, Andrew J. Carroll, Jonathan E. Kolitz, Bayard L. Powell, Jessica Kohlschmidt, R. M. Stone, John C. Byrd, Krzysztof Mrózek, C. D. Bloomfield
13
18
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
2016 ·Leukemia ·(unknown), Jessica Kohlschmidt, Sebastian Schwind, Deedra Nicolet, James S. Blachly, Shelley Orwick, (unknown), (unknown), (unknown), Christopher J. Walker, Andrew J. Carroll, Bayard L. Powell, Richard M. Stone, Jonathan E. Kolitz, Maria R. Baer, Albert de la Chapelle, Krzysztof Mrózek, John C. Byrd, Clara D. Bloomfield
42
19
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
2015 ·Leukemia ·Adrienne M. Dorrance, Paolo Neviani, Gregory Ferenchak, Xiaomeng Huang, Deedra Nicolet, Kati Maharry, Hatice Gülçin Özer, (unknown), Jihane Khalife, Emily B. Hill, Marshleen Yadav, Brad Bolon, (unknown), (unknown), Carlo M. Croce, Ramiro Garzon, Michael A. Caligiuri, Clara D. Bloomfield, Guido Marcucci
85
20
Relationship between use of antidepressants and risk of fractures: a meta-analysis
2012 ·Osteoporosis International ·Véronique Rabenda, Deedra Nicolet, Charlotte Beaudart, Olivier Bruyère, J.-Y. Reginster
87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Guo Breakdown of academic impact, for papers by Judith Neukirchen Breakdown of academic impact, for papers by Varsha Muralidhar Breakdown of academic impact, for papers by H.C. Kwaan Breakdown of academic impact, for papers by Chengming Fei Breakdown of academic impact, for papers by Alan Hair Breakdown of academic impact, for papers by Marianne Bach Treppendahl Breakdown of academic impact, for papers by Kosei Oshima Breakdown of academic impact, for papers by C.C So Breakdown of academic impact, for papers by Toshio Shigekiyo
Rankless by CCL
2026